NONPEPTIDE NEUROTENSIN RECEPTOR ANTAGONISTS AS POTENTIAL ANTIPSYCHOTIC-DRUGS

被引:0
|
作者
SOUBRIE, P [1 ]
GULLY, D [1 ]
机构
[1] SANOFI RECH,F-34184 MONTPELLIER 04,FRANCE
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:267 / MEDI
相关论文
共 50 条
  • [21] ANTIPSYCHOTIC-DRUGS AND DEMENTIA
    不详
    GERONTOLOGIST, 1980, 20 (05): : 179 - 179
  • [22] NEW ANTIPSYCHOTIC-DRUGS
    LOO, H
    BROCHIER, T
    MEIDINGER, A
    PRESSE MEDICALE, 1991, 20 (19): : 889 - 890
  • [23] NEWER ANTIPSYCHOTIC-DRUGS - A REVIEW OF THEIR PHARMACOLOGY AND THERAPEUTIC POTENTIAL
    KANE, JM
    DRUGS, 1993, 46 (04) : 585 - 593
  • [24] SIGMA-RECEPTOR ANTAGONISTS AS POTENTIAL ANTIPSYCHOTIC-DRUGS .2. ANIMAL BEHAVIORAL-TESTING OF NOVEL PIPERIDINE-DERIVATIVES
    GILLIGAN, PJ
    CAIN, GA
    CHRISTOS, TE
    COOK, L
    DRUMMOND, S
    JOHNSON, AL
    KERGAYE, AA
    MCELROY, JF
    ROHRBACH, KW
    SCHMIDT, WK
    TAM, SW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 84 - MEDI
  • [25] NOVEL DOPAMINE-RECEPTOR SUBTYPES AS TARGETS FOR ANTIPSYCHOTIC-DRUGS
    SOKOLOFF, P
    DIAZ, J
    LEVESQUE, D
    PILON, C
    DIMITRIADOU, V
    GRIFFON, N
    LAMMERS, CH
    MARTRES, MP
    SCHWARTZ, JC
    DIVERSITY OF INTERACTING RECEPTORS, 1995, 757 : 278 - 292
  • [26] ANTIPSYCHOTIC-DRUGS, NEUROTRANSMITTERS, AND SCHIZOPHRENIA
    CARLSSON, A
    AMERICAN JOURNAL OF PSYCHIATRY, 1978, 135 (02): : 164 - 173
  • [27] BLOCKADE OF DOPAMINE RECEPTOR - POSSIBLE MECHANISM OF ACTION OF ANTIPSYCHOTIC-DRUGS
    KAROBATH, ME
    PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1975, 8 (04): : 151 - 161
  • [28] DOSAGE FOR ANTIPSYCHOTIC-DRUGS (CONCL)
    ANDERSON, WH
    KUEHNLE, JC
    NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (03): : 173 - 174
  • [29] ANTIPSYCHOTIC-DRUGS BLOCK PHENCYCLIDINE RECEPTOR-MEDIATED NEUROTOXICITY
    FARBER, NB
    PRICE, MT
    LABRUYERE, J
    NEMNICH, J
    STPETER, H
    WOZNIAK, DF
    OLNEY, JW
    BIOLOGICAL PSYCHIATRY, 1993, 34 (1-2) : 119 - 121
  • [30] ANTIPSYCHOTIC-DRUGS - COMPREHENSION QUIZ
    HARTSHORN, EA
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1975, 9 (10): : 550 - 552